Litcius/Paper detail

MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases

Flavia Plastino, Noemi Anna Pesce, Helder André

2021Acta Ophthalmologica42 citationsDOI

Abstract

Ocular neovascular diseases, such as proliferative diabetic retinopathy, retinopathy of prematurity and neovascular age-related macular degeneration, are the leading causes of visual impairment worldwide. The hypoxia-inducible factors and vascular endothelial growth factors are key molecular promoters of ocular neovascularization. Moreover, the role of microRNAs as regulators of angiogenesis has been expanding, particularly hypoxia-associated microRNA; hypoxamiRs. This review provides a summary of hypoxamiRs that directly and specifically target HIF1A and VEGF mRNAs, thus critically involved in the regulation of ocular neovascular pathologies. The discussed microRNAs highlight putative diagnostic markers and therapeutic agents in choroidal and retinal angiogenic diseases, including proliferative diabetic retinopathy, retinopathy of prematurity and neovascular age-related macular degeneration.

Topics & Concepts

Macular degenerationRetinopathy of prematurityMedicineDiabetic retinopathyAngiogenesismicroRNAHypoxia (environmental)NeovascularizationOphthalmologyChoroidal neovascularizationVascular endothelial growth factorRetinalRetinaBioinformaticsCancer researchPathologyVEGF receptorsBiologyDiabetes mellitusEndocrinologyNeuroscienceGeneticsGeneGestational ageChemistryOrganic chemistryOxygenPregnancyCancer-related molecular mechanisms researchMicroRNA in disease regulationAngiogenesis and VEGF in Cancer
MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases | Litcius